Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al

Affiliations

¹ Allergy and Immunology Division, Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Department of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Department of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA.
⁵ Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Rheumatology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁷ Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁸ Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Comment

John H Stone et al. Ann Rheum Dis. 2015 Aug.

. 2015 Aug;74(8):e47.

doi: 10.1136/annrheumdis-2015-207640. Epub 2015 Apr 28.

¹ Allergy and Immunology Division, Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Department of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Department of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA.
⁵ Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Rheumatology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁷ Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁸ Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA.

No abstract available

Keywords: Rehabilitation; Rheumatoid Arthritis; Treatment.

Comment on

Rituximab for IgG4-related disease: a prospective, open-label trial.
Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S, Stone JH. Carruthers MN, et al. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605. Epub 2015 Feb 9. Ann Rheum Dis. 2015. PMID: 25667206
Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years.
Yamamoto M, Awakawa T, Takahashi H. Yamamoto M, et al. Ann Rheum Dis. 2015 Aug;74(8):e46. doi: 10.1136/annrheumdis-2015-207625. Epub 2015 Apr 10. Ann Rheum Dis. 2015. PMID: 25862615 No abstract available.